Modulation of DPK cell function by the kappa opioid agonist U50,488H.
Guan
L
L
Department of Microbiology and Immunology, Temple University School of Medicine Philadelphia, Pennsylvania 19140, USA.
Eisenstein
T K
TK
Adler
M W
MW
Rogers
T J
TJ
D019900:3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer / Q000494:pharmacology*; D000818:Animals; D015704:CD4 Antigens; D016827:CD8 Antigens; D002460:Cell Line; D007376:Interleukin-2 / Q000096:biosynthesis; D019891:Leukopoiesis / Q000187:drug effects / Q000502:physiology*; D008297:Male; D051379:Mice; D015375:Receptors, Interleukin-2 / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D017473:Receptors, Opioid, kappa / Q000819:agonists / Q000502:physiology*; D013601:T-Lymphocytes / Q000166:cytology* / Q000187:drug effects
D015704:CD4 Antigens; D016827:CD8 Antigens; D007376:Interleukin-2; D015375:Receptors, Interleukin-2; D017473:Receptors, Opioid, kappa; D019900:3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer